A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)
Clinical trial NCT03224182 · TERMINATED
Trial details
- NCT number
- NCT03224182
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-04
- Primary completion
- 2019-09-26
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.